全文获取类型
收费全文 | 504篇 |
免费 | 26篇 |
国内免费 | 3篇 |
专业分类
耳鼻咽喉 | 1篇 |
儿科学 | 68篇 |
妇产科学 | 25篇 |
基础医学 | 48篇 |
口腔科学 | 33篇 |
临床医学 | 38篇 |
内科学 | 89篇 |
皮肤病学 | 24篇 |
神经病学 | 26篇 |
特种医学 | 13篇 |
外科学 | 76篇 |
综合类 | 7篇 |
预防医学 | 12篇 |
眼科学 | 33篇 |
药学 | 17篇 |
中国医学 | 1篇 |
肿瘤学 | 22篇 |
出版年
2023年 | 3篇 |
2022年 | 7篇 |
2021年 | 10篇 |
2020年 | 7篇 |
2019年 | 14篇 |
2018年 | 16篇 |
2017年 | 13篇 |
2016年 | 9篇 |
2015年 | 20篇 |
2014年 | 19篇 |
2013年 | 21篇 |
2012年 | 36篇 |
2011年 | 43篇 |
2010年 | 33篇 |
2009年 | 36篇 |
2008年 | 55篇 |
2007年 | 52篇 |
2006年 | 42篇 |
2005年 | 34篇 |
2004年 | 30篇 |
2003年 | 15篇 |
2002年 | 8篇 |
2001年 | 2篇 |
1999年 | 2篇 |
1997年 | 2篇 |
1995年 | 2篇 |
1994年 | 2篇 |
排序方式: 共有533条查询结果,搜索用时 7 毫秒
531.
532.
Nilgun Altin Fatma Aybala Altay Murat Albayrak Seyda Ozdemir Sahingoz Irfan Sencan 《Journal of medical virology》2023,95(1):e28182
Crimean-Congo hemorrhagic fever (CCHF) is a viral hemorrhagic fever, which is common in Turkey and globally. The pathogenesis of coagulation disorders, which is seen in viral hemorrhagic fevers remains to be elucidated. Thrombin-activatable fibrinolysis inhibitor (TAFI) has a key role in this process In this study, we aimed to evaluate whether TAFI levels contributed to bleeding and whether it is related to prognosis in CCHF patients. Eighty-four patients older than 15 years of age, who were admitted to our hospital who had positive immunoglobulin M (enzyme-linked immunosorbent assay [ELISA]) and/or polymerase chain reaction test results for CCHF between 2009 and 2010, were included in the study. The control group included 30 healthy adults. The plasma TAFI levels were compared between patients and controls, and also between patients with bleeding and no bleeding, and between patients with mild-moderate and severe disease. The mean TAFI levels were lower in patients (mean: 87.82 ng/ml, median: 61.69 ng/ml (interquartile range [IQR] 30.49–537.95) than controls (mean: 313.5 ng/ml with a median: 338.5 ng/ml (IQR 182–418). However, median TAFI levels were significantly higher in patients with bleeding compared to those without bleeding (78.99 and 50.28 ng/ml, respectively; p = 0.032). Median IQR TAFI levels were similar between patients with mild-moderate and severe disease (64.72 (41.37–113.85), and, 58.66 (42.44–118.93) ng/ml, respectively; p = 0.09) and survivors and nonsurvivors (86.14 ± 77.98 and 103.48 ± 69.92, respectively; p = 0.3). Although TAFI levels were lower in the patients with CCHF compared to healthy controls, it does not seem to be a major player in the prognosis. 相似文献